New Edge Advisors, LLC Ocular Therapeutix, Inc Transaction History

New Edge Advisors, LLC

  • $11.2 Billion
  • Q1 2024

A detailed history of New Edge Advisors, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 1,480 shares of OCUL stock, worth $10,123. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,480
Previous 1,480 -0.0%
Holding current value
$10,123
Previous $6,000 116.67%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$3.14 - $5.04 $34,540 - $55,440
-11,000 Reduced 88.14%
1,480 $4,000
Q2 2023

Aug 14, 2023
BUY
$4.6 - $7.64 $50,599 - $84,040
11,000 Added 743.24%
12,480 $64,000
Q1 2023

May 12, 2023
SELL
$2.79 - $6.27 $25,110 - $56,429
-9,000 Reduced 85.88%
1,480 $7,000
Q3 2022

Nov 14, 2022
SELL
$4.09 - $6.5 $4,090 - $6,500
-1,000 Reduced 8.71%
10,480 $43,000
Q1 2022

May 13, 2022
SELL
$4.83 - $7.35 $9,660 - $14,700
-2,000 Reduced 14.84%
11,480 $57,000
Q3 2021

Oct 29, 2021
SELL
$9.7 - $14.34 $2,910 - $4,302
-300 Reduced 2.18%
13,480 $135,000
Q1 2021

Apr 26, 2021
SELL
$15.82 - $22.11 $85,000 - $118,797
-5,373 Reduced 28.05%
13,780 $226,000
Q4 2020

Jan 27, 2021
SELL
$7.91 - $22.95 $22,361 - $64,879
-2,827 Reduced 12.86%
19,153 $396,000
Q3 2020

Nov 03, 2020
SELL
$7.36 - $9.87 $14,720 - $19,740
-2,000 Reduced 8.34%
21,980 $167,000
Q2 2020

Jul 29, 2020
SELL
$4.67 - $8.95 $2,335 - $4,475
-500 Reduced 2.04%
23,980 $200,000
Q1 2020

May 04, 2020
SELL
$3.95 - $7.4 $5,925 - $11,100
-1,500 Reduced 5.77%
24,480 $121,000
Q4 2019

Jan 31, 2020
BUY
$2.57 - $4.73 $66,768 - $122,885
25,980 New
25,980 $102,000
Q3 2019

Nov 06, 2019
SELL
$3.04 - $5.32 $85,880 - $150,290
-28,250 Closed
0 $0
Q2 2019

Aug 05, 2019
SELL
$2.46 - $4.52 $19,680 - $36,160
-8,000 Reduced 22.07%
28,250 $124,000
Q1 2019

May 14, 2019
BUY
$3.51 - $4.77 $127,237 - $172,912
36,250 New
36,250 $144,000
Q1 2019

May 09, 2019
SELL
$3.51 - $4.77 $127,237 - $172,912
-36,250 Closed
0 $0
Q4 2018

Jan 29, 2019
SELL
$3.87 - $7.11 $19,350 - $35,550
-5,000 Reduced 12.12%
36,250 $144,000
Q4 2017

Feb 08, 2018
SELL
$3.73 - $6.37 $11,190 - $19,110
-3,000 Reduced 6.78%
41,250 $200,000
Q3 2017

Nov 13, 2017
SELL
$5.28 - $6.88 $15,840 - $20,640
-3,000 Reduced 6.35%
44,250 $268,000
Q2 2017

Aug 16, 2017
BUY
N/A
47,250
47,250 $0

Others Institutions Holding OCUL

# of Institutions
148
Shares Held
123M
Call Options Held
185K
Put Options Held
507K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $526M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email